Streetbeat News

Stock Prices

RDHL

RedHill Biopharma Ltd. (RDHL) has been approved to transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market due to non-compliance with the minimum Market Value of Publicly Held Shares requirement. The transfer will occur on November 15, 2023, without affecting trading under the ticker RDHL. The company also faces a compliance issue with the minimum bid price requirement and has until March 18, 2024, to meet this standard or potentially receive an additional compliance period.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:12 pm

DSS

DSS, Inc. (NYSE:DSS) successfully defended its ‘040 Patent against Nichia Corp.'s challenge in the Court of Appeals for the Federal Circuit. The court upheld a previous USPTO decision affirming the patent's validity. DSS plans to pursue Nichia for patent infringement damages related to its LED product line.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:11 pm

URGN

UroGen Pharma (NASDAQ:URGN) reported Q3 earnings with a loss of $(0.68) per share, surpassing the $(0.85) estimate, and sales of $20.85M, exceeding the $20.03M estimate. This reflects a significant improvement over the previous year with a 39.82% decrease in losses and a 29.54% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:09 pm

CHR

FAZE

GETY

HRYU

KBNT

LVO

SNAP

TGL

TRVG

VSME

In Tuesday's pre-market session, several communication services stocks showed significant movement. Hanryu Holdings (HRYU), Treasure Global (TGL), VS Media Holdings (VSME), Getty Images Holdings (GETY), and Snap (SNAP) experienced gains, with HRYU leading at a 22.7% increase. Conversely, trivago (TRVG), Kubient (KBNT), Sea (SE), Cheer Holding (CHR), LiveOne (LVO), and FaZe Hldgs (FAZE) saw their shares fall, with TRVG and KBNT experiencing the largest declines at 43.9% and 40.37%, respectively. Earnings reports influenced several of these stock movements.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:06 pm

AKLI

BCDA

BDRX

BTAI

GNFT

HROW

INVO

RDHL

RNLX

TCON

TENX

THRX

In Tuesday's pre-market session, several healthcare stocks showed significant movement. BioCardia (BCDA) saw a substantial increase of 115.5% to $0.86, while BioXcel Therapeutics (BTAI) experienced a sharp decline of 37.9% to $3.42. Other notable gainers included Theseus Pharmaceuticals (THRX), INVO Bioscience (INVO), Genfit (GNFT), Redhill Biopharma (RDHL), and Biodexa Pharmaceuticals (BDRX). On the losing side, Harrow (HROW), Tenax Therapeutics (TENX), Akili (AKLI), Renalytix (RNLX), and TRACON Pharma (TCON) saw their stock prices fall. The movements were largely attributed to recent earnings reports.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:06 pm

ASUR

AUVI

BAER

BEEM

BGLC

BWEN

ISUN

JTAI

LICY

MVST

NPWR

SUNW

In Tuesday's pre-market session, several industrial stocks showed significant movement. Gainers included BioNexus Gene Lab (BGLC), Jet AI (JTAI), Beam Glb (BEEM), Broadwind (BWEN), Sunworks (SUNW), and Microvast Holdings (MVST), with increases ranging from 6.34% to 15.1%, largely attributed to recent Q3 earnings releases. Losers were Applied UV (AUVI), Bridger Aerospace Gr (BAER), Li-Cycle Holdings (LICY), iSun (ISUN), Asure Software (ASUR), and NET Power (NPWR), with declines between 5.26% and 33.3%, also following their Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:06 pm

AIRE

CSIQ

DAVE

EVLV

PRSO

QMCO

In Tuesday's pre-market session, several information technology stocks showed significant movement. ReAlpha Tech Corp (AIRE) saw an 85.0% increase to $10.9, while Dave (DAVE) rose by 26.92% to $6.6. Quantum (QMCO) and Evolv Technologies (EVLV) also experienced gains. Conversely, Peraso (PRSO), Canadian Solar (CSIQ), and other stocks such as Bit Origin (BTOG) and HeartCore Enterprises (HTCR) faced declines. Earnings reports seem to be a driving factor for many of these movements.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:06 pm

NYCB

Wedbush analyst David Chiaverini downgraded New York Community (NYSE:NYCB) from Neutral to Underperform and reduced the price target from $12 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:06 pm

URGN

UroGen Pharma (NASDAQ:URGN) reported Q3 earnings with an EPS of $-0.68, beating estimates by 20.0% against an expected $-0.85. Revenue increased by $4.75 million compared to the same period last year. The company had previously beaten EPS estimates last quarter, which led to a 4.48% rise in share price the following day. Historical earnings and revenue figures were also provided for the past four quarters.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:05 pm

SGRP

SPAR Group (NASDAQ:SGRP) reported Q3 earnings with an EPS of $0.02, beating estimates by 100% but with a revenue decline of $2.50 million from the same period last year. The previous quarter's earnings miss resulted in a 4.49% share price drop the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:05 pm